Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease
Chronic hepatitis B virus (HBV) infection is a major global cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Despite current antiviral therapies, functional cure remains elusive due to persistent HBsAg expression and immune dysfunct…